Mandate

Vinge advises founder and major shareholders on the sale of Dynamic Code AB

September 17, 2021 M&A

Vinge is advising the founder and major shareholders in connection with the sale of Dynamic Code AB.

Dynamic Code develops and sells self-sampling kits based on DNA technology. The samples are analysed in Dynamic Code’s own lab and the test results are obtained through a code online. Care and treatment is thereafter offered via digital health care providers and Dynamic Code has, based on that, been able to create a complete chain of health care through its e-health platform.

Closing of the transaction is subject to due diligence and that shareholders representing 95 per cent of all shares in Dynamic Code adhere to the share transfer agreement.

The Vinge team includes Anna Edström, Magnus Hedsund and Niklas Törnell.

 

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025